NYSE:OPRX - OptimizeRx Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$16.57 -1.41 (-7.84 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$17.98
Today's Range$16.49 - $18.10
52-Week Range$2.30 - $18.39
Volume381,280 shs
Average Volume48,982 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. It has a strategic partnership with Patient Connect to deliver real-time messaging at point-of-care in Europe. OptimizeRx Corporation is based in Rochester, Michigan.

Receive OPRX News and Ratings via Email

Sign-up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
SymbolNYSE:OPRX
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares11,640,000
Market Cap$0.00

OptimizeRx (NYSE:OPRX) Frequently Asked Questions

What is OptimizeRx's stock symbol?

OptimizeRx trades on the New York Stock Exchange (NYSE) under the ticker symbol "OPRX."

How were OptimizeRx's earnings last quarter?

OptimizeRx Corp. (NYSE:OPRX) announced its quarterly earnings results on Tuesday, August, 7th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.02) by $0.04. The business had revenue of $5.10 million for the quarter, compared to analyst estimates of $4.34 million. View OptimizeRx's Earnings History.

When is OptimizeRx's next earnings date?

OptimizeRx is scheduled to release their next quarterly earnings announcement on Thursday, November, 1st 2018. View Earnings Estimates for OptimizeRx.

What is the consensus analysts' recommendation for OptimizeRx?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptimizeRx in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OptimizeRx.

Who are some of OptimizeRx's key competitors?

Who are OptimizeRx's key executives?

OptimizeRx's management team includes the folowing people:
  • Mr. William J. Febbo, CEO & Director (Age 49)
  • Ms. Miriam J. Paramore, Pres (Age 55)
  • Mr. Douglas P. Baker, Chief Financial Officer (Age 61)
  • Mr. Terence J. Hamilton, Sr. VP of Sales (Age 53)
  • Mr. Ed Berger, Sr. VP of Marketing

Has OptimizeRx been receiving favorable news coverage?

Press coverage about OPRX stock has trended somewhat positive on Friday, according to Accern Sentiment. Accern ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. OptimizeRx earned a coverage optimism score of 0.18 on Accern's scale. They also gave news coverage about the company an impact score of 46.57 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for OptimizeRx.

How do I buy shares of OptimizeRx?

Shares of OPRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OptimizeRx's stock price today?

One share of OPRX stock can currently be purchased for approximately $16.57.


MarketBeat Community Rating for OptimizeRx (NYSE OPRX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  53
MarketBeat's community ratings are surveys of what our community members think about OptimizeRx and other stocks. Vote "Outperform" if you believe OPRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2018 by MarketBeat.com Staff

Featured Article: Investing in Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel